NSE/EMCURE (NSE/EMCURE)

National Stock Exchange of India: NSE/EMCURE · INR

₹1,868

-7.13 (-0.4%)· Recorded snapshot

Market cap	355.7B
Revenue (ttm)	96.8B
Net income (ttm)	10.1B
EPS (ttm)	₹53.4
Shares out	189.7M
P/E (trailing)	35.0x
P/E (forward)	28.1x
Dividend	₹3.60 (0.19%)
Volume	62,132
Beta	-0.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 96.8B
Net income (ttm): 10.1B
EPS (ttm): ₹53.4
P/E (trailing): 35.0x
P/E (forward): 28.1x
Market cap: 355.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.1

P25 n/aP50 n/aP75 n/a

Trailing P/E35

P25 n/aP50 n/aP75 n/a

ROE19.6

P25 n/aP50 n/aP75 n/a

ROIC16.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NSE/EMCURE indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

INR

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-03
Employees	6,914
Employees change	183
Employees growth	2.72%
Enterprise value	INR 369.7B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	INE168P01015
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Market cap	INR 355.7B
Next earnings date	2026-11-03
Price	INR 1,868.00
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	nse/EMCURE
Website	https://www.emcure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	33.03x
Average P/E ratio (3Y)	35.54x
Earnings yield	2.86%
EV/Earnings	36.55x
EV/EBIT	25.19x
EV/EBITDA	19.41x
EV/FCF	63.41x
EV/Sales	3.82x
FCF / EV yield	1.58%
FCF yield	1.64%
Forward P/E	28.06x
Graham number	559.86994
Graham upside	-70.03%
Industry forward P/E	33.04x
Industry P/E	38.96x
Lynch fair value	INR 1,333.78
Lynch upside	-28.6%
P/(FCF - SBC) ratio	61.3x
P/(OCF - SBC) ratio	37.81x
P/B ratio	7.15x
P/E ratio	35.01x
P/FCF ratio	61.01x
P/OCF ratio	37.69x
P/S ratio	3.67x
PEG ratio	1.37x
Price / tangible book value	9.24x
Price/EBITDA ratio	18.67x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.16%
EBITDA margin	19.67%
Effective tax rate	26.69%
FCF margin	6.33%
Gross margin	59.43%
Operating margin	15.16%
Pretax margin	14.35%
Profit margin	10.44%
Profit per employee	INR 1.5M
Profitable quarters	8
Profitable years	2
Revenue per employee	INR 14M
ROA	9.62%
ROA (5Y)	9.12%
ROCE	24.1%
ROE	19.57%
ROE (5Y)	22.2%
ROIC	16.93%
ROIC (5Y)	16.1%
SBC / revenue	0.03%
Tax / revenue	3.83%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	35.57%
EPS growth (Q)	41.94%
EPS growth (QoQ)	20.72%
EPS growth 3Y	20.38%
EPS growth 5Y	30.57%
EPS growth quarters	4
EPS growth years	1
FCF growth	-7.45%
FCF growth 3Y	17.84%
Gross profit growth	18.91%
Gross profit growth (Q)	16.08%
Gross profit growth 3Y	15.03%
Gross profit growth 5Y	58.79%
Net income growth	35.9%
Net income growth (Q)	42.05%
Net income growth (QoQ)	20.78%
Net income growth 3Y	22.28%
Net income growth 5Y	38.77%
Net income growth quarters	4
Net income growth years	1
OCF growth	10.78%
OCF growth 3Y	8.1%
OCF growth 5Y	50.27%
Operating income growth	28.02%
Operating income growth (Q)	30.9%
Operating income growth 3Y	15.58%
Operating income growth 5Y	52.69%
Revenue growth	18.36%
Revenue growth (Q)	22.85%
Revenue growth (QoQ)	4.48%
Revenue growth 3Y	16.36%
Revenue growth 5Y	55.82%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -3.6B
Depreciation and amortization	INR 4.4B
EBIT	INR 14.7B
EBITDA	INR 19B
EPS	INR 53.35
FCF per share	INR 30.74
Financing cash flow	INR 3.4B
Free cash flow	INR 5.8B
Free cash flow minus SBC	INR 5.8B
Gross profit	INR 57.6B
Income taxes	INR 3.7B
Investing cash flow	INR -11.9B
Net borrowing	INR 4.9B
Net cash flow	INR 1.1B
Net income	INR 10.1B
Operating cash flow minus SBC	INR 9.4B
Operating income	INR 14.7B
Revenue	INR 96.8B
Stock-based compensation	INR 28.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 261.12
Debt / EBITDA	0.8
Debt / equity	0.31
Debt / FCF	2.61
Interest coverage	9.89
Net cash (debt)	INR -13.7B
Net cash / market cap	-3.86%
Net debt / EBITDA	0.72
Net debt / equity	0.28
Net debt / FCF	2.36
Piotroski F-Score	5
Shareholders' equity	INR 49.8B
Tangible book value	INR 38.5B
Tangible book value per share	INR 203.04
Total cash	INR 1.5B
Total debt	INR 15.2B
WACC	3.96%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.03
Current ratio	1.43
Inventory turnover	1.68
Quick ratio	0.71
Working capital	INR 17B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.24%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-10-21
Dividend payment years	2
Dividend per share	INR 3.60
Dividend yield	0.19%
Ex-dividend date	2026-09-04
FCF payout ratio	11.71%
Last dividend	INR 3.60
Payout ratio	6.75%
Shareholder yield	-0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 1,795.24
1D price change	-0.38%
1M price change	-4.23%
1M total return	-4.23%
1W price change	5.74%
1W total return	5.74%
1Y price change	38.48%
1Y return CAGR	38.78%
1Y total return	38.75%
20-day SMA	INR 1,858.31
200-day SMA	INR 1,719.97
3M price change	-2.95%
3M total return	-2.76%
50-day SMA	INR 1,890.92
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,100.70
52-week high date	2026-09-18
52-week low	INR 1,306.50
52-week low date	2025-11-04
6M price change	14.04%
6M total return	14.26%
All-time high	INR 2,100.70
All-time high date	2026-09-18
All-time low	INR 889.00
All-time low date	2025-04-07
Average true range (ATR)	INR 61.69
Average volume	112.3K
Beta (1Y)	-0
Beta (2Y)	0.18
Beta (5Y)	-0.08
Change from 52-week high	-11.08%
Change from 52-week low	42.98%
Change from all-time high	-11.08%
Change from all-time low	110.12%
Change from open	-0.41%
Day's gap	0.03%
Dollar volume	INR 116.1M
High price	INR 1,889.20
Low price	INR 1,839.90
Monthly RSI	61.16
Open price	INR 1,875.70
Position in 52-week range	57%
Previous close	INR 1,875.20
Price vs 150-day SMA	4.05%
Price vs 20-day SMA	0.52%
Price vs 200-day SMA	8.61%
Price vs 50-day SMA	-1.21%
Relative volume	0.55
RSI	51
Sharpe ratio	1
Sortino ratio	1.8
Volume	62.1K
Weekly RSI	55.25
YTD price change	36.9%
YTD total return	37.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41.8M
Shares change (QoQ)	0.05%
Shares change (YoY)	0.24%
Shares held by insiders	70.34%
Shares held by institutions	13.88%
Shares outstanding	189.7M

Deeper analysis on NSE/EMCURE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NSE/EMCURE report

Is a complete NSE/EMCURE research report available?

No complete published report is available for nse/EMCURE (NSE/EMCURE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/EMCURE (NSE/EMCURE)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/EMCURE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/EMCURE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/EMCURE

Frequently asked questions